The Breast Cancer Research Foundation is a nonprofit organization committed to achieving prevention and a cure for breast cancer. We provide critical funding for cancer research worldwide to fuel advances in tumor biology, genetics, prevention, treatment, metastasis and survivorship.

Since our founding in 1993 by Evelyn H. Lauder, BCRF has raised more than a billion dollars to fuel its mission to be the end of breast cancer. Through a unique and streamlined grants program, we seek out the brightest minds in science and medicine and give them the necessary resources to pursue their best ideas. This enables researchers to make discoveries and design new approaches to address all aspects of breast cancer—and do so in record time.

“Our goal is to accelerate breakthroughs. We’re on the verge of important advances in precision prevention. More promising targeted treatments are in the works today. And for the first time, we can envision cures for metastatic disease.” — Myra J. Biblowit, President & CEO

In 2022-2023, BCRF will award $52.7 million in annual grants to 255 scientists from top universities and medical institutions around the globe. In addition, BCRF has established the Evelyn H. Lauder Founder’s Fund, a multi-year international program to unravel the biology of metastasis. It is the largest privately funded project exclusively focused on metastasis in the world.

The thousands of women and men suffering from breast cancer today depend on us. No institution can conquer this disease alone. Together, we can.